Advanced skin cancer guidance

Final draft guidance recommends nivolumab for advanced skin cancer

The National Institute for Health and Care Excellence (NICE) England, on Friday 22 January said yes to nivolumab as monotherapy for treating advanced skin cancer in final draft guidance. ….more

Leave a Comment

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.